Pacira BioSciences Inc. Common Stock (PCRX)

About PCRX

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the manage…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

825

Website

www.pacira.com

Fundamentals

1-day range

$22.79$23.37

Market cap

$1.06B

P/E (trailing)

65.71

P/E (forward)

6.63

EPS (trailing)

$0.35

Dividend yield

—

Beta

0.27

Avg. volume

555.9K

Forecasts

6 analyst ratings

Pacira BioSciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• PCRX

  Pacira BioSciences Inc. Common Stock

  $25.76

  ▼ 0.27%
  Market cap $1.06BP/E 65.71
  $18.8$27.66
• LXRX

  Lexicon Pharmaceuticals Inc. Common Stock

  $2.29

  ▼ 1.29%
  Market cap $1.03BP/E —
  $1.03$2.68
• SVRA

  Savara Inc. Common Stock

  $5.27

  ▼ 4.10%
  Market cap $1.09BP/E —
  $3.19$7.01
• IVA

  Inventiva S.A. American Depository Shares

  $4.71

  ▼ 3.98%
  Market cap $1.00BP/E —
  $2.88$6.2
• CRVS

  Corvus Pharmaceuticals Inc. Common Stock

  $14.15

  ▼ 3.87%
  Market cap $1.12BP/E —
  $5.28$26.95
• OLMA

  Olema Pharmaceuticals Inc. Common Stock

  $10.28

  ▼ 4.77%
  Market cap $985.28MP/E —
  $5.36$36.26
• SDGR

  Schrodinger Inc. Common Stock

  $19.7

  ▼ 3.48%
  Market cap $1.14BP/E —
  $10.95$23.02

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

40.23M

Total value held

$886.84M

Institutional holders

232